| 147362-15-0 | b-D-Xylopyranoside, (3b,5a,15b,24S)-15,24-dihydroxycholesta-7,9(11)-dien-3-yl 2-O-methyl- (9CI) | C33H54 O7 |
| 147362-16-1 | Cholestane-4,6,15,24-tetrol,3-[(2-O-methyl-b-D-xylopyranosyl)oxy]-,(3b,4b,5a,6b,15b,24S)- (9CI) | C33H58 O9 |
| 147362-17-2 | Cholestane-4,6,8,15,24-pentol,3-[(2-O-methyl-b-D-xylopyranosyl)oxy]-,(3b,4b,5a,6b,15b,24S)- (9CI) | C33H58 O10 |
| 147362-18-3 | SEe Stigmastane-3,4,6,8,15,16-hexol,29-[(4-O-RL- arabinopyranosyl-3-O-methyl-â-Dxylopyranosyl) oxy]-,(3â,4â,5R,6R,15â,16â,24R)- |
| 147362-19-4 | Stigmast-22-ene-3,4,6,8,15,16-hexol,29-[(4-O-a-L-arabinopyranosyl-3-O-methyl-b-D-xylopyranosyl)oxy]-, (3b,4b,5a,6a,15b,16b,22E,24R)- (9CI) | C40H68 O15 |
| 147362-20-7 | Stigmastane-3,4,6,8,15,16-hexol,29-[(O-3-O-methyl-b-D-xylopyranosyl-(1®4)-O-3-O-methyl-b-D-xylopyranosyl-(1®4)-b-D-xylopyranosyl)oxy]-, (3b,4b,5a,6a,15b,16b,24R)- (9CI) | C46H80 O19 |
| 147362-21-8 | Stigmastane-3,4,6,8,15,16-hexol,29-[(O-3-O-methyl-b-D-xylopyranosyl-(1®4)-O-b-D-xylopyranosyl-(1®4)-b-D-xylopyranosyl)oxy]-, (3b,4b,5a,6a,15b,16b,24R)- (9CI) | C45H78 O19 |
| 147362-22-9 | D-arabino-Hexitol,1,5-dideoxy-6-C-[2-[(S)-[(12-methyl-1-oxotridecyl)oxy]-5-oxazolylmethyl]-4-oxazolyl]-,(6S)- | C27H44 N2 O8 |
| 147362-23-0 | D-arabino-Hexitol,1,5-dideoxy-6-C-[(S)-2-[5-oxazolyl[(1-oxopentadecyl)oxy]methyl]-4-oxazolyl]-,(6S)- | C28H46 N2 O8 |
| 147362-24-1 | D-arabino-Hexitol,1,5-dideoxy-6-C-[2-[(S)-5-oxazolyl[(1-oxohexadecyl)oxy]methyl]-4-oxazolyl]-,(6S)- | C29H48 N2 O8 |
| 147362-37-6 | 5H-Dibenzo[c,g]carbazole-5,9(7H)-dione,6,8-bis(3,4-dihydroxyphenyl)-2,3,11,12-tetrahydroxy-7-[2-(4-hydroxyphenyl)ethyl]- | C40H27 N O11 |
| 147362-43-4 | triptoditerpenic acid B | C21H28 O3 |
| 147362-49-0 | 2-Propenoic acid,3-[2-(3,4-dihydroxyphenyl)-3,4-dihydro-4-oxo-2H-1,5-benzodioxepin-6-yl]- (9CI) | C18H14 O7 |
| 147362-51-4 | 2H-3,9a-Methano-1-benzoxepin-9-carboxylicacid, octahydro-2,2,5a-trimethyl-, (3R,5aS,9S,9aS)- | C15H24 O3 |
| 147362-57-0 | Loviride | C17H16 Cl2 N2 O2 |